Elevated IL-6 levels in the synovial fluid of osteoarthritis patients stem from plasma cells

Scandinavian Journal of Rheumatology

Volumn 36, Issue 2, 2007, Pages 136-139

  Doss F ^a   Menard, J ^b   Hauschild, M ^a   Kreutzer, H J ^a   Mittlmeier, T ^a   Muller Steinhardt M ^c   Muller B ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b German Natl Research Cent for   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

AGED; ARTHROPLASTY; ARTICLE; ARTICULAR CARTILAGE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIP OSTEOARTHRITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KNEE OSTEOARTHRITIS; MALE; OSTEOARTHRITIS; PLASMA CELL; PRIORITY JOURNAL; SERUM; SYNOVIAL FLUID; SYNOVIUM;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; PLASMA CELLS; SYNOVIAL FLUID; SYNOVIAL MEMBRANE;

EID: 34247613052     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740701250785     Document Type: Article

References (15)

1. Buckwalter JA, Saltzman C, Brown T, Schurman DJ. The impact of osteoarthritis: implications for research. Clin Orthop 2004: S6-15.
2. van den Berg WB, van der Kraan PM, Scharstuhl A, van Beuningen HM. Growth factors and cartilage repair. Clin Orthop Relat Res 2001: S244-50.
3. Vergunst CE, van de Sande MG, Lebre MC, Tak PP. The role of chemokines in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 2005;34:415-25.
4. Moos V, Rudwaleit M, Herzog V, Hohlig K, Sieper J, Muller B. Association of genotypes affecting the expression of interleukin-1beta or interleukin-1 receptor antagonist with osteoarthritis. Arthritis Rheum 2000;43:2417-22.
5. Muller B. Cytokine imbalance in non-immunological chronic disease. Cytokine 2002;18:334-9.
6. Sanchez C, Deberg MA, Piccardi N, Msika P, Reginster JY, Henrotin YE. Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes. This effect is mimicked by interleukin-6, -1β and oncostatin M pre-treated non-sclerotic osteoblasts. Osteoarthritis Cartilage 2005;13:979-87.
7. Jikko A, Wakisaka T, Iwamoto M, Hiranuma H, Kato Y, Maeda T, Fujishita M, et al. Effects of interleukin-6 on proliferation and proteoglycan metabolism in articular chondrocyte cultures. Cell Biol Int 1998;22:615-21.
8. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, et al. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 1988;332:83-5.
9. Reddy SV. Regulatory mechanisms operative in osteoclasts. Crit Rev Eukaryot Gene Expr 2004;14:255-70.
10. Muller-Steinhardt M, Hartel C, Muller B, Kirchner H, Fricke L. The interleukin-6 2174 promoter polymorphism is associated with long-term kidney allograft survival. Kidney Int 2002;62:1824-7.
11. Kaneko S, Satoh T, Chiba J, Ju C, Inoue K, Kagawa J. Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis. Cytokines Cell Mol Ther 2000;6:71-9.
12. Massicotte F, Lajeunesse D, Benderdour M, Pelletier J-P, Hilal G, Duval N, et al. Can altered production of interleukin-1beta, interleukin-6, transforming growth factor-beta and prostaglandin E2 by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients? Osteoarthritis Cartilage 2002;10:491-500.
13. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102:1369-76.
14. Pola E, Papaleo P, Pola R, Gaetani E, Tamburelli FC, Aulisa L, Logroscino CA. Interleukin-6 gene polymorphism and risk of osteoarthritis of the hip: a case-control study. Osteoarthritis Cartilage 2005;13:1025-8.
15. Yokota S, Miyamae T, Imagawa T, Iwata N, Katakura S, Mori M, et al. Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemiconset juvenile idiopathic arthritis. Arthritis Rheum 2005;52:818-25.